insights_auto
Why is INO down 3.79%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$1.40
arrow_downward
-3.79%(-0.055) 1D
ኖቬም 11, 10:47:43 ጥዋት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$1.37
High
US$1.43
Low
US$1.30
Mkt. cap
235.66 ሚ
Avg. vol.
18.79 ሚ
Volume
4.62 ሚ
52-wk high
US$2.72
52-wk low
US$0.57
EPS
-US$1.17
Beta
1.71
Shares outstanding
103.40 ሚ
No. of employees
112
Open
US$1.37
High
US$1.43
Low
US$1.30
Mkt. cap
235.66 ሚ
Avg. vol.
18.79 ሚ
Volume
4.62 ሚ
52-wk high
US$2.72
52-wk low
US$0.57
EPS
-US$1.17
Beta
1.71
Shares outstanding
103.40 ሚ
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
ከ25 ደቂቃዎች በፊት
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
ከ2 ሰዓቶች በፊት
INOVIO to Participate in Upcoming Investor Conferences
GuruFocus
·
ከ12 ሰዓቶች በፊት
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
TradingView
·
ከ13 ሰዓቶች በፊት
Inovio Pharmaceuticals Q3 2026 Earnings Call Is Live
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com